nodes	percent_of_prediction	percent_of_DWPC	metapath
Fenoldopam—ADRA1D—epithelium—cervical cancer	0.0178	0.0793	CbGeAlD
Fenoldopam—ADRA1B—renal system—cervical cancer	0.0169	0.0752	CbGeAlD
Fenoldopam—DRD5—female reproductive system—cervical cancer	0.0165	0.0735	CbGeAlD
Fenoldopam—DRD5—female gonad—cervical cancer	0.015	0.0669	CbGeAlD
Fenoldopam—ADRA1D—female reproductive system—cervical cancer	0.0132	0.0589	CbGeAlD
Fenoldopam—ADRA1A—epithelium—cervical cancer	0.0102	0.0456	CbGeAlD
Fenoldopam—ADRA2C—uterine cervix—cervical cancer	0.00967	0.0431	CbGeAlD
Fenoldopam—ADRA1A—renal system—cervical cancer	0.00949	0.0423	CbGeAlD
Fenoldopam—ADRA2C—decidua—cervical cancer	0.00921	0.041	CbGeAlD
Fenoldopam—ADRA2C—renal system—cervical cancer	0.00905	0.0403	CbGeAlD
Fenoldopam—ADRA2C—endometrium—cervical cancer	0.00875	0.0389	CbGeAlD
Fenoldopam—ADRA2C—mammalian vulva—cervical cancer	0.00846	0.0377	CbGeAlD
Fenoldopam—ADRA2C—uterus—cervical cancer	0.00806	0.0359	CbGeAlD
Fenoldopam—ADRA2A—uterine cervix—cervical cancer	0.00772	0.0344	CbGeAlD
Fenoldopam—ADRA2A—decidua—cervical cancer	0.00735	0.0327	CbGeAlD
Fenoldopam—ADRA2A—endometrium—cervical cancer	0.00698	0.0311	CbGeAlD
Fenoldopam—ADRA2A—mammalian vulva—cervical cancer	0.00675	0.0301	CbGeAlD
Fenoldopam—ADRA2C—female gonad—cervical cancer	0.00659	0.0293	CbGeAlD
Fenoldopam—ADRA2C—vagina—cervical cancer	0.00655	0.0292	CbGeAlD
Fenoldopam—ADRA2A—uterus—cervical cancer	0.00643	0.0286	CbGeAlD
Fenoldopam—ADRA2A—female reproductive system—cervical cancer	0.00578	0.0257	CbGeAlD
Fenoldopam—ADRA2A—female gonad—cervical cancer	0.00526	0.0234	CbGeAlD
Fenoldopam—ADRA2A—vagina—cervical cancer	0.00523	0.0233	CbGeAlD
Fenoldopam—ADRA1B—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.00449	0.00579	CbGpPWpGaD
Fenoldopam—ADRA2B—Hemostasis—GP5—cervical cancer	0.00439	0.00566	CbGpPWpGaD
Fenoldopam—ADRA2C—lymph node—cervical cancer	0.00424	0.0189	CbGeAlD
Fenoldopam—DRD1—GPCR ligand binding—TAAR6—cervical cancer	0.00418	0.00539	CbGpPWpGaD
Fenoldopam—DRD2—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.00414	0.00534	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR ligand binding—TAAR6—cervical cancer	0.00412	0.00531	CbGpPWpGaD
Fenoldopam—ADRA2C—Hemostasis—GP5—cervical cancer	0.0041	0.00529	CbGpPWpGaD
Fenoldopam—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.00399	0.00515	CbGpPWpGaD
Fenoldopam—ADRA2A—Hemostasis—SERPIND1—cervical cancer	0.00381	0.00491	CbGpPWpGaD
Fenoldopam—ADRA2A—Hemostasis—GP6—cervical cancer	0.00381	0.00491	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR ligand binding—TAAR6—cervical cancer	0.00372	0.0048	CbGpPWpGaD
Fenoldopam—DRD5—GPCR ligand binding—WNT5A—cervical cancer	0.00372	0.0048	CbGpPWpGaD
Fenoldopam—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.00371	0.00478	CbGpPWpGaD
Fenoldopam—DRD5—GPCR downstream signaling—TAAR6—cervical cancer	0.00355	0.00458	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR ligand binding—TAAR6—cervical cancer	0.00348	0.00448	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR ligand binding—TAAR6—cervical cancer	0.00342	0.00441	CbGpPWpGaD
Fenoldopam—ADRA2A—lymph node—cervical cancer	0.00338	0.0151	CbGeAlD
Fenoldopam—ADRA2A—Hemostasis—GP5—cervical cancer	0.00333	0.0043	CbGpPWpGaD
Fenoldopam—DRD1—GPCR ligand binding—WNT2—cervical cancer	0.00326	0.00421	CbGpPWpGaD
Fenoldopam—DRD5—Signaling by GPCR—TAAR6—cervical cancer	0.00323	0.00416	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR ligand binding—WNT2—cervical cancer	0.00322	0.00415	CbGpPWpGaD
Fenoldopam—DRD2—GPCR ligand binding—TAAR6—cervical cancer	0.00315	0.00407	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR ligand binding—TAAR6—cervical cancer	0.00304	0.00392	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR ligand binding—WNT2—cervical cancer	0.0029	0.00375	CbGpPWpGaD
Fenoldopam—ADRA1B—AMPK Signaling—MTOR—cervical cancer	0.0029	0.00374	CbGpPWpGaD
Fenoldopam—ADRA1B—LPA receptor mediated events—CASP3—cervical cancer	0.00283	0.00365	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR ligand binding—TAAR6—cervical cancer	0.00282	0.00364	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR ligand binding—WNT2—cervical cancer	0.00271	0.0035	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR ligand binding—WNT2—cervical cancer	0.00267	0.00344	CbGpPWpGaD
Fenoldopam—ADRA1A—AMPK Signaling—MTOR—cervical cancer	0.00258	0.00332	CbGpPWpGaD
Fenoldopam—DRD5—Signaling by GPCR—WNT2—cervical cancer	0.00252	0.00325	CbGpPWpGaD
Fenoldopam—DRD1—GPCR ligand binding—WNT5A—cervical cancer	0.00247	0.00319	CbGpPWpGaD
Fenoldopam—DRD2—GPCR ligand binding—WNT2—cervical cancer	0.00246	0.00317	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR ligand binding—WNT5A—cervical cancer	0.00244	0.00314	CbGpPWpGaD
Fenoldopam—DRD5—GPCR downstream signaling—AKAP13—cervical cancer	0.00243	0.00314	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR ligand binding—WNT2—cervical cancer	0.00237	0.00306	CbGpPWpGaD
Fenoldopam—DRD1—GPCR downstream signaling—TAAR6—cervical cancer	0.00236	0.00304	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR downstream signaling—TAAR6—cervical cancer	0.00233	0.003	CbGpPWpGaD
Fenoldopam—DRD5—Signaling by GPCR—AKAP13—cervical cancer	0.00221	0.00285	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR ligand binding—WNT2—cervical cancer	0.0022	0.00284	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR ligand binding—WNT5A—cervical cancer	0.0022	0.00284	CbGpPWpGaD
Fenoldopam—ADRA1B—LPA receptor mediated events—EGFR—cervical cancer	0.00216	0.00279	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—TAAR6—cervical cancer	0.00214	0.00276	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—TAAR6—cervical cancer	0.00211	0.00273	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—TAAR6—cervical cancer	0.0021	0.00271	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR ligand binding—WNT5A—cervical cancer	0.00206	0.00265	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR ligand binding—WNT5A—cervical cancer	0.00202	0.00261	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—TAAR6—cervical cancer	0.00196	0.00253	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—TAAR6—cervical cancer	0.00193	0.00249	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—TAAR6—cervical cancer	0.00191	0.00246	CbGpPWpGaD
Fenoldopam—DRD5—Signaling by GPCR—WNT5A—cervical cancer	0.00191	0.00246	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—TAAR6—cervical cancer	0.00191	0.00246	CbGpPWpGaD
Fenoldopam—DRD2—GPCR ligand binding—WNT5A—cervical cancer	0.00187	0.00241	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR ligand binding—WNT5A—cervical cancer	0.0018	0.00232	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—TAAR6—cervical cancer	0.00178	0.0023	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—TAAR6—cervical cancer	0.00178	0.0023	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—TAAR6—cervical cancer	0.00176	0.00226	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—TAAR6—cervical cancer	0.00172	0.00221	CbGpPWpGaD
Fenoldopam—ADRA1B—AMPK Signaling—TP53—cervical cancer	0.00171	0.00221	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—WNT2—cervical cancer	0.00167	0.00216	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR ligand binding—WNT5A—cervical cancer	0.00167	0.00215	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—WNT2—cervical cancer	0.00165	0.00213	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—TAAR6—cervical cancer	0.00162	0.00209	CbGpPWpGaD
Fenoldopam—DRD1—GPCR downstream signaling—AKAP13—cervical cancer	0.00162	0.00209	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR downstream signaling—AKAP13—cervical cancer	0.0016	0.00206	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—TAAR6—cervical cancer	0.0016	0.00206	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—TAAR6—cervical cancer	0.00156	0.00201	CbGpPWpGaD
Fenoldopam—ADRA1A—AMPK Signaling—TP53—cervical cancer	0.00152	0.00196	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—WNT2—cervical cancer	0.00149	0.00192	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—WNT2—cervical cancer	0.00149	0.00192	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—AKAP13—cervical cancer	0.00147	0.00189	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—AKAP13—cervical cancer	0.00145	0.00187	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—TAAR6—cervical cancer	0.00145	0.00187	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—AKAP13—cervical cancer	0.00144	0.00186	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—WNT2—cervical cancer	0.00139	0.0018	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—WNT2—cervical cancer	0.00137	0.00177	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—AKAP13—cervical cancer	0.00135	0.00174	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—AKAP13—cervical cancer	0.00132	0.00171	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—AKAP13—cervical cancer	0.00131	0.00169	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—AKAP13—cervical cancer	0.00131	0.00168	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—WNT5A—cervical cancer	0.00127	0.00164	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—TAAR6—cervical cancer	0.00127	0.00163	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—WNT2—cervical cancer	0.00126	0.00163	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—WNT5A—cervical cancer	0.00125	0.00161	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—TAAR6—cervical cancer	0.00125	0.00161	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—AKAP13—cervical cancer	0.00122	0.00158	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—AKAP13—cervical cancer	0.00122	0.00158	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—WNT2—cervical cancer	0.00122	0.00157	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—AKAP13—cervical cancer	0.0012	0.00155	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—AKAP13—cervical cancer	0.00118	0.00152	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—WNT2—cervical cancer	0.00113	0.00146	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—WNT5A—cervical cancer	0.00113	0.00146	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—TAAR6—cervical cancer	0.00113	0.00145	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—WNT5A—cervical cancer	0.00113	0.00145	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—AKAP13—cervical cancer	0.00111	0.00143	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—AKAP13—cervical cancer	0.00109	0.00141	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—AKAP13—cervical cancer	0.00107	0.00138	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—WNT5A—cervical cancer	0.00106	0.00136	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—TAAR6—cervical cancer	0.00105	0.00136	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—WNT5A—cervical cancer	0.00104	0.00134	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—TAAR6—cervical cancer	0.00104	0.00134	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—AKAP13—cervical cancer	0.000993	0.00128	CbGpPWpGaD
Fenoldopam—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000989	0.00128	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—WNT2—cervical cancer	0.000988	0.00127	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—WNT2—cervical cancer	0.000975	0.00126	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—WNT5A—cervical cancer	0.000957	0.00123	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—TAAR6—cervical cancer	0.000956	0.00123	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—CA9—cervical cancer	0.000929	0.0012	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—WNT5A—cervical cancer	0.000922	0.00119	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—TAAR6—cervical cancer	0.000921	0.00119	CbGpPWpGaD
Fenoldopam—DRD1—Circadian rythm related genes—TP53—cervical cancer	0.000888	0.00115	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—WNT2—cervical cancer	0.000881	0.00114	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—AKAP13—cervical cancer	0.000868	0.00112	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—WNT5A—cervical cancer	0.000857	0.00111	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—AKAP13—cervical cancer	0.000856	0.0011	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—TAAR6—cervical cancer	0.000856	0.0011	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—WNT2—cervical cancer	0.000822	0.00106	CbGpPWpGaD
Fenoldopam—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000821	0.00106	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—WNT2—cervical cancer	0.000809	0.00104	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—NOTCH2—cervical cancer	0.000791	0.00102	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—AKAP13—cervical cancer	0.000773	0.000997	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—CA9—cervical cancer	0.000754	0.000973	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—WNT5A—cervical cancer	0.000749	0.000966	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—WNT2—cervical cancer	0.000746	0.000962	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—WNT5A—cervical cancer	0.000739	0.000953	CbGpPWpGaD
Fenoldopam—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000729	0.00094	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—AKAP13—cervical cancer	0.000722	0.000931	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—WNT2—cervical cancer	0.000719	0.000927	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—AKAP13—cervical cancer	0.000711	0.000917	CbGpPWpGaD
Fenoldopam—DRD2—Circadian rythm related genes—TP53—cervical cancer	0.00067	0.000865	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—WNT2—cervical cancer	0.000668	0.000862	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—WNT5A—cervical cancer	0.000667	0.000861	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—AKAP13—cervical cancer	0.000655	0.000845	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—HES1—cervical cancer	0.000649	0.000837	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—AKAP13—cervical cancer	0.000631	0.000814	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—WNT5A—cervical cancer	0.000623	0.000804	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—WNT5A—cervical cancer	0.000613	0.000791	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—AKAP13—cervical cancer	0.000587	0.000756	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—TERT—cervical cancer	0.000569	0.000733	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—WNT5A—cervical cancer	0.000566	0.000729	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—WNT5A—cervical cancer	0.000545	0.000703	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—NOTCH2—cervical cancer	0.000526	0.000678	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—FGFR3—cervical cancer	0.000522	0.000673	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—NOTCH2—cervical cancer	0.000519	0.000669	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—WNT5A—cervical cancer	0.000506	0.000653	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—NOTCH1—cervical cancer	0.00049	0.000632	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—NOTCH2—cervical cancer	0.000468	0.000604	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—NOTCH2—cervical cancer	0.000437	0.000564	CbGpPWpGaD
Fenoldopam—DRD5—Signaling by GPCR—EGFR—cervical cancer	0.000436	0.000563	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—HES1—cervical cancer	0.000431	0.000556	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—NOTCH2—cervical cancer	0.000431	0.000555	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—HES1—cervical cancer	0.000425	0.000549	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—NOTCH2—cervical cancer	0.000397	0.000512	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—HES1—cervical cancer	0.000384	0.000495	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—NOTCH2—cervical cancer	0.000382	0.000493	CbGpPWpGaD
Fenoldopam—ADRA2B—Hemostasis—TP53—cervical cancer	0.000378	0.000487	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—TERT—cervical cancer	0.000378	0.000487	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—MTHFR—cervical cancer	0.000377	0.000486	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—TERT—cervical cancer	0.000373	0.000481	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—MTOR—cervical cancer	0.000367	0.000473	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—HES1—cervical cancer	0.000359	0.000463	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—NOTCH2—cervical cancer	0.000355	0.000458	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—HES1—cervical cancer	0.000353	0.000455	CbGpPWpGaD
Fenoldopam—ADRA2C—Hemostasis—TP53—cervical cancer	0.000353	0.000455	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—FGFR3—cervical cancer	0.000347	0.000447	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—FGFR3—cervical cancer	0.000342	0.000441	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—CASP3—cervical cancer	0.000338	0.000435	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—TERT—cervical cancer	0.000336	0.000434	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—HES1—cervical cancer	0.000325	0.00042	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—NOTCH1—cervical cancer	0.000325	0.00042	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—CTNNB1—cervical cancer	0.000325	0.00042	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—NOTCH1—cervical cancer	0.000321	0.000414	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—TERT—cervical cancer	0.000314	0.000405	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—HES1—cervical cancer	0.000314	0.000404	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—TERT—cervical cancer	0.000309	0.000399	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—FGFR3—cervical cancer	0.000309	0.000398	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—MTHFR—cervical cancer	0.000306	0.000395	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—HES1—cervical cancer	0.000291	0.000376	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—EGFR—cervical cancer	0.00029	0.000374	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—NOTCH1—cervical cancer	0.00029	0.000374	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—FGFR3—cervical cancer	0.000288	0.000372	CbGpPWpGaD
Fenoldopam—ADRA2A—Hemostasis—TP53—cervical cancer	0.000287	0.00037	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—EGFR—cervical cancer	0.000286	0.000369	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—TERT—cervical cancer	0.000285	0.000368	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—FGFR3—cervical cancer	0.000284	0.000366	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—STAT3—cervical cancer	0.000284	0.000366	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—TERT—cervical cancer	0.000275	0.000354	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—NOTCH1—cervical cancer	0.000271	0.000349	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—NOTCH1—cervical cancer	0.000267	0.000344	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—FGFR3—cervical cancer	0.000262	0.000338	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—EGFR—cervical cancer	0.000258	0.000333	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—EGFR—cervical cancer	0.000258	0.000332	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—TERT—cervical cancer	0.000255	0.000329	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—FGFR3—cervical cancer	0.000252	0.000325	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—NOTCH1—cervical cancer	0.000246	0.000317	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—MTOR—cervical cancer	0.000244	0.000315	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—EGFR—cervical cancer	0.000241	0.000311	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—MTOR—cervical cancer	0.000241	0.00031	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—EGFR—cervical cancer	0.000237	0.000306	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—NOTCH1—cervical cancer	0.000237	0.000305	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—FGFR3—cervical cancer	0.000234	0.000302	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—CASP3—cervical cancer	0.000224	0.000289	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—CASP3—cervical cancer	0.000221	0.000285	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—NOTCH1—cervical cancer	0.00022	0.000284	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—EGFR—cervical cancer	0.000219	0.000282	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—MTOR—cervical cancer	0.000217	0.00028	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—TP53—cervical cancer	0.000216	0.000279	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—CTNNB1—cervical cancer	0.000216	0.000279	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—CTNNB1—cervical cancer	0.000213	0.000275	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—EGFR—cervical cancer	0.000211	0.000272	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—MTOR—cervical cancer	0.000203	0.000262	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CASP3—cervical cancer	0.0002	0.000258	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—MTOR—cervical cancer	0.0002	0.000258	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—EGFR—cervical cancer	0.000196	0.000253	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CTNNB1—cervical cancer	0.000193	0.000248	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—STAT3—cervical cancer	0.000188	0.000243	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CASP3—cervical cancer	0.000187	0.000241	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—STAT3—cervical cancer	0.000186	0.00024	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—MTOR—cervical cancer	0.000184	0.000237	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CASP3—cervical cancer	0.000184	0.000237	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CTNNB1—cervical cancer	0.00018	0.000232	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—MTOR—cervical cancer	0.000177	0.000229	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CTNNB1—cervical cancer	0.000177	0.000228	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—EGFR—cervical cancer	0.000171	0.000221	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CASP3—cervical cancer	0.000169	0.000218	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—EGFR—cervical cancer	0.000169	0.000218	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—STAT3—cervical cancer	0.000168	0.000217	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—MTOR—cervical cancer	0.000165	0.000213	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CTNNB1—cervical cancer	0.000163	0.000211	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CASP3—cervical cancer	0.000163	0.00021	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CTNNB1—cervical cancer	0.000157	0.000203	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—STAT3—cervical cancer	0.000157	0.000202	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—STAT3—cervical cancer	0.000154	0.000199	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—EGFR—cervical cancer	0.000153	0.000197	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CASP3—cervical cancer	0.000152	0.000196	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CTNNB1—cervical cancer	0.000146	0.000188	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—TP53—cervical cancer	0.000144	0.000185	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—EGFR—cervical cancer	0.000143	0.000184	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—STAT3—cervical cancer	0.000142	0.000184	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—TP53—cervical cancer	0.000142	0.000183	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—EGFR—cervical cancer	0.00014	0.000181	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—STAT3—cervical cancer	0.000137	0.000177	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—EGFR—cervical cancer	0.000129	0.000167	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—TP53—cervical cancer	0.000128	0.000165	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—STAT3—cervical cancer	0.000127	0.000164	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—EGFR—cervical cancer	0.000125	0.000161	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—TP53—cervical cancer	0.00012	0.000154	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—TP53—cervical cancer	0.000118	0.000152	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—EGFR—cervical cancer	0.000116	0.000149	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—TP53—cervical cancer	0.000109	0.00014	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—TP53—cervical cancer	0.000105	0.000135	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—TP53—cervical cancer	9.72e-05	0.000125	CbGpPWpGaD
